IRIS
ASCARI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.726
AS - Asia 3.788
EU - Europa 3.010
SA - Sud America 419
AF - Africa 91
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.627
CN - Cina 2.041
SG - Singapore 784
IE - Irlanda 692
UA - Ucraina 470
HK - Hong Kong 368
FI - Finlandia 367
DE - Germania 349
BR - Brasile 318
RU - Federazione Russa 290
SE - Svezia 272
VN - Vietnam 248
FR - Francia 165
GB - Regno Unito 157
IT - Italia 125
IN - India 96
CA - Canada 58
ZA - Sudafrica 46
AR - Argentina 41
BD - Bangladesh 41
IQ - Iraq 25
JP - Giappone 23
NL - Olanda 23
BE - Belgio 19
ID - Indonesia 17
IR - Iran 17
PL - Polonia 17
MX - Messico 16
VE - Venezuela 16
ES - Italia 15
PK - Pakistan 15
EC - Ecuador 13
SA - Arabia Saudita 13
CO - Colombia 12
UZ - Uzbekistan 12
AU - Australia 11
TR - Turchia 11
JO - Giordania 10
MA - Marocco 10
AT - Austria 8
DZ - Algeria 8
KE - Kenya 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
PH - Filippine 7
PY - Paraguay 7
DK - Danimarca 6
EG - Egitto 6
CL - Cile 5
CR - Costa Rica 5
NP - Nepal 5
AZ - Azerbaigian 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
UY - Uruguay 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KZ - Kazakistan 3
LT - Lituania 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
Totale 12.048
Salva come PNG Salva come JPEG
Città #
Dublin 689
Chandler 591
Jacksonville 570
San Jose 541
Nanjing 455
Singapore 396
Ashburn 381
Hong Kong 357
Beijing 295
Dallas 291
Boardman 209
Nanchang 191
Princeton 137
Shenyang 126
Hebei 125
Lawrence 125
Medford 121
Changsha 114
Wilmington 112
Los Angeles 111
Lauterbourg 104
Jiaxing 99
Helsinki 92
Ann Arbor 77
Ho Chi Minh City 77
Tianjin 74
Hangzhou 72
Munich 70
New York 64
Hanoi 58
Moscow 57
Buffalo 49
Shanghai 44
Milan 43
Redondo Beach 43
Johannesburg 40
Turku 37
Council Bluffs 36
Woodbridge 33
Norwalk 28
São Paulo 28
Santa Clara 25
Verona 24
Montreal 23
Orem 23
Tokyo 22
Toronto 21
Seattle 20
Chicago 19
Fairfield 19
Brussels 18
Houston 16
Denver 15
Guangzhou 15
Warsaw 15
Brooklyn 13
Haiphong 13
Kunming 13
Manchester 13
Da Nang 12
Phoenix 12
San Francisco 12
Chennai 11
Des Moines 11
Frankfurt am Main 11
Jinan 11
London 11
Zhengzhou 11
Boston 10
Brasília 10
The Dalles 10
Auburn Hills 9
Falkenstein 9
Poplar 9
Rio de Janeiro 9
Tashkent 9
Atlanta 8
Baghdad 8
Nairobi 8
Ningbo 8
Piscataway 8
Quito 8
San Genesio Ed Uniti 8
Taizhou 8
Amsterdam 7
Belo Horizonte 7
Mumbai 7
New Delhi 7
Amman 6
Changchun 6
Columbus 6
Delhi 6
Falls Church 6
Jeddah 6
Mexico City 6
Orange 6
Rome 6
Andover 5
Ardabil 5
Bắc Ninh 5
Totale 7.827
Salva come PNG Salva come JPEG
Nome #
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 168
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 162
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 159
Acute promyelocitic leukemia toluidine blue subtype. 155
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 139
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 139
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 139
Anomalous erythrocytes produced by rabbits with liver damage. 137
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 133
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 128
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 128
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 126
Acute phase proteins and prognosis in multiple myeloma. 125
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 122
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 122
AMYLOIDOSIS AL 121
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 119
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 119
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 119
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 119
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 117
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 117
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 116
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 115
Acquired immune thrombastenia: a new bleeding disorder. 115
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 114
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 112
Possible evolution of human parvovirus B19 infection into erythroleukemia 111
Silymarine during maintenance therapy of acute promyelocytic leukemia. 110
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 110
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 109
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 109
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 109
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 107
Anemie megaloblastiche. 107
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 105
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 104
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 104
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 104
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 102
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 102
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 102
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 102
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 101
Changing clinical presentation of multiple myeloma. 100
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 100
[Chronic granulomatous disease with sea-blue histiocytosis: a case report (author's transl)]. 100
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 99
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 99
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 99
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 98
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 96
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 96
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 96
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 96
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 95
Biologia e clinica del mieloma multiplo. 95
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 95
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 94
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 93
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 93
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 93
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 92
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 91
Fisiopatologia dell'eritrocito. 91
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 91
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 91
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 90
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 90
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 89
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 89
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 89
Chemotherapy-induced leukonychia 89
Glycopeptides of erythrocyte membranes in some hematological disorders 88
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 88
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 87
Acute promyelocytic leukemia: morphological and clinical features. 86
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 85
Applicazioni cliniche dei fattori di crescita emopoietici. 85
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 85
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 84
Surface mechanisms of platelet adhesion and aggregation 84
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 82
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 81
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 81
Applicazioni cliniche della citometria. 81
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 81
Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. 81
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 81
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. 81
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 80
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 79
IL MIELOMA MULTIPLO 79
Loss of the Y chromosome in smoldering acute leukemia. 79
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 78
Terapia del mieloma multiplo. 78
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 77
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 77
Erythrocyte membrane modifications in chronic granulocytic leukaemia 76
Biologic and clinical significance of red cell ferritin. 76
Totale 10.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/20251.566 44 142 37 52 25 49 53 109 391 47 183 434
2025/20263.908 275 254 441 523 421 220 809 135 343 278 100 109
2026/202752 52 0 0 0 0 0 0 0 0 0 0 0
Totale 12.127